FIELD: chemistry.
SUBSTANCE: invention concerns biotechnology and nanotechnology. The method includes transforming archaeal cells with a recombinant plasmid, growing cells, selecting flagella and modifying the surface of the flagella. The plasmid structure contains recombinant genes for synthesis of flagellins A1 and A2 which form flagella, wherein the sequence of flagellin A1 or flagellin A2 or sequences of flagellin A and flagellin A2 contain at least one peptide insert for selective binding of metal ions or nanoparticles. The point of the peptide insert in flagellin A1 is defined in the region between first and second glycosylation sites located between position 86 and position 96 of SEQ ID NO:2, and the point of the peptide insert in flagellin A2 is defined in the region between first and second glycosylation sites located between position 82 and position 92 of SEQ ID NO:3, where the length of the peptide insert is 5 to 60 amino acids. The method includes selecting archaeal flagella containing peptide inserts for non-covalent bonding with metal ions, performing fragmentation of flagella into fragments and modifying the surface of flagella by binding peptide inserts with metal ions and oxidising metals, washing, drying and packing the obtained nano-structured material.
EFFECT: method enables to obtain a coating for forming active surfaces on flexible and solid substrates or capsules using archaeal flagella, which enable non-covalent bonding of a wide range of substances such as metal ions, metal nanoparticles, semiconductors and other ligands.
6 cl, 11 dwg, 1 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING NANOSTRUCTURED MATERIAL BASED ON RECOMBINANT ARCHEA FLAGELLA | 2009 |
|
RU2522833C2 |
PLASMID VECTOR pHYP WITH HIGH SEGREGATION STABILITY FOR EXPRESSION OF RECOMBINANT PROTEIN, BACTERIUM - PRODUCENT OF PRECURSOR OF RECOMBINANT PROTEIN AND METHOD TO PRODUCE RECOMBINANT PROTEIN | 2011 |
|
RU2496877C2 |
PaCas9 NUCLEASE | 2018 |
|
RU2706298C1 |
IMPROVED VECTOR EXPRESSING TOLL-LIKE RECEPTOR AND AGONIST, AND USE IN CANCER THERAPY | 2014 |
|
RU2682762C2 |
METHOD FOR GIVING THE PLANTS THE RESISTANCE TO WEED-SUPPRESSING COMPOUNDS | 1999 |
|
RU2292396C2 |
RECOMBINANT PLASMID DNA pHIG05, CODING HYBRID PROTEIN WITH HUMAN PROINSULIN Glargine, CELL Escherichia coli, TRANSFORMED BY RECOMBINANT PLASMID DNA PHIG05, AND STRAIN OF BACTERIA Escherichia coli JM109/pHIG05-PRODUCENT OF HYBRID PROTEIN WITH HUMAN PROINSULIN Glargine | 2013 |
|
RU2515115C1 |
CELL LINE HUFSHKKC6, PRODUCER OF RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE (FSH) AND METHOD FOR PRODUCING FSH USING SAID LINE | 2018 |
|
RU2694598C1 |
METHOD FOR THE PREPARATION OF SURFACTANT PEPTIDES | 2013 |
|
RU2628088C2 |
OBTAINING PHOSPHOLIPASE A2 GENE WITH CHANGED pH OPTIMUM BY REMOVING GLYCOSYLATION SITES | 2019 |
|
RU2766448C2 |
RECOMBINANT PLASMID FOR EXPRESSION IN PICHIA PASTORIS YEAST GENE OF CHIMERIC PROTEIN OF HUMAN ANGIOGENIN AND STRAIN OF PICHIA PASTORIS YEAST - PRODUCER OF RECOMBINANT CHIMERIC PROTEIN OF HUMAN ANGIOGENIN | 2017 |
|
RU2658758C1 |
Authors
Dates
2014-08-20—Published
2010-04-19—Filed